N4 Pharma PLC (LSE:N4P) - Share price - Overview


Stock Report

N4 Pharma PLC N4P

Last Price
GBX7.10

Day Change
-0.05|-0.70%

As of 25/03/2019
10:05:04 GMT | GBX
Minimum 15 Minutes Delay.

Last Close7.15p
Day Range7.00 - 7.00
Mkt Cap7.26Mil
52-Wk Range3.50 - 28.43
Yield %0.00
ISINGB00BYW8QM32
Volume51,111
P/E-7.76
P/S-
P/CF-0.05

Share Price

Total Returns 22/03/2019

 Chg (%)  
More ...
N4 Pharma PLC-11.18 
FTSE 100 TR GBP0.93
 
Financials
201520162017
More ...
Income Statement
Turnover0.001.16-
Operating Profit-0.16-0.03-0.62
Net Profit-0.15-0.02-1.84
Reported EPS-1.20-0.08-2.84
Balance Sheet
Current Assets0.610.601.46
Non Current Assets0.050.520.00
Total Assets0.661.121.46
Current Liabilities0.020.080.18
Total Liabilities---
Total Equity0.641.041.28
Cash Flow
Operating Cash Flow-0.88-0.38-0.95
Net Change in Cash0.24-0.421.31

Regulatory News

Company Profile

N4 Pharma PLC is a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance. Its vaccines include Nuvac and Nuvec.

Sector

Drug Manufacturers - Major

Index

FTSE AIM All-Share

Next Event 25/04/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-48.18
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Date12/11/9623/05/97
Ex-Div04/11/9619/05/97
Paid02/12/9601/07/97
Amnt17.2018.00
Directors
More ...
Non-Executive DirectorLuke Sebastian Cairns
Executive DirectorPaul Titley
Executive Director, Chief Executive OfficerNigel Theobald
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.